Product Information

EXEMESTANE 25 MG TABLET is a generic product labeled by Florida Pharmaceutical Products, LLC, priced at $0.6303 per EA under NDC 71921019033. Its NADAC has been published 266 times since Oct 13, 2021.

FDA first approved this application on Apr 13, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EXEMESTANE 25 MG TABLET

Exemestane
$0.6303per EA

Strength

25 mg/1

NDC

71921019033

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

EXEMESTANE

Approval Type

Generic (ANDA)

FDA Application

ANDA213547

FDA Approved

4/13/2020

TE Code

AB

On Market Since

1/15/2021

Pharmacological Classes

Aromatase Inhibitor
Aromatase Inhibitors

Price Statistics

The NADAC for EXEMESTANE 25 MG TABLET has been published 266 times since Oct 13, 2021, and over the history we have for it it has declined 61.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6303 per EA
All-time high$1.8650 (Nov 10, 2021)
All-time low$0.5602 (Jul 17, 2024)
52-week high$0.7478
52-week low$0.5751
Median price$0.8514
Average price$0.8856
Largest weekly change+39.9% (Jan 18, 2023)
Weeks tracked266
Tracking sinceOct 13, 2021

Price History

1W

0.0%

1M

-15.7%

3M

-8.3%

6M

+1.5%

1Y

-4.4%

3Y

-29.2%

5Y

-66.2%

All

-61.7%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EXEMESTANE 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EXEMESTANE 25 MG TABLET, manufactured by Florida Pharmaceutical Products, LLC, is $0.6303 per EA (NDC 71921019033), effective Nov 11, 2026.

How has the price of EXEMESTANE 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for EXEMESTANE 25 MG TABLET has declined 61.7%. It has been tracked across 266 weekly CMS publications since Oct 13, 2021.

What are the highest and lowest recorded NADAC prices for EXEMESTANE 25 MG TABLET?

Since Oct 13, 2021, the NADAC for EXEMESTANE 25 MG TABLET has ranged from a low of $0.5602 (Jul 17, 2024) to a high of $1.8650 (Nov 10, 2021), with a median of $0.8514 per EA.

Are there cheaper alternatives to EXEMESTANE 25 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EXEMESTANE 25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures EXEMESTANE 25 MG TABLET?

EXEMESTANE 25 MG TABLET (NDC 71921019033) is labeled by Florida Pharmaceutical Products, LLC, and CMS classifies it as a generic product.